Table 3.

Multivariate predictive model for factors influencing physicians decision on anaphylaxis diagnosis and first-line management choice. Statistically significant difference (p<0.05) appear in bold

Respondents characteristic	Diagnosed patient with anaphylaxis, %	OR (95% CI)	p Value	Used adrenalin 1:1000 intramuscular, %	OR (95% CI)	p Value	Used prednisolone intramuscular, %	OR (95% CI)	p Value	Used chloropyramine, %	OR (95% CI)	p Value
Clinical settings Primary care/private practice Secondary and/or tertiary care	29 41	0.59 (0.36 to 0.98)	0.04	13 18	0.68 (0.35 to 1.29)	0.23	41 30	1.60 (0.96 to 2.66)	0.07	27 24	1.18 (0.69 to 2.05	0.54
Clinical experience (years) 1–10 >10	32 34	0.92 (0.50 to 1.69)	0.79	15 15	0.99 (0.45 to 2.20)	0.99	38 37	1.07 (0.60 to 1.91)	0.83	28 26	1.13 (0.60 to 2.12)	0.71
Specialty Paediatrics	34	1.22	0.46	16	1.36 (0.67 to 2.77)	0.40	39 32	1.36 (0.82 to 2.28)	0.23	29 22	1.43 (0.81 to 2.53)	0.22
Other specialities	30	(0.72 to 2.05)		13